➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Mallinckrodt
McKinsey
Baxter
Boehringer Ingelheim

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 8,121,712

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,121,712
Title:System and method for determining an offensive, defensive, and cumulative efficiency of a sports team
Abstract: A system and method is described for determining a scoring efficiency of a team engaged in a sport, such as baseball, softball or other sport in which runners attempt to advance from a series of base positions. A memory or database stores a total number of runs scored from scoring position and a total number of individual base runners that reached base from a single at-bat, over a predetermined interval, such as an inning, a series of innings, a game or a series of games. A processor, coupled to the memory, determine scoring efficiency by determining a ratio between the number of runs scored from scoring position and the total number of individual base runners that reached base from a single at-bat. An output device operatively connected the processor receives the scoring efficiency calculated by the processor and transmits or displays the scoring efficiency for evaluation of a team\'s efficiency in scoring from scoring position or preventing scoring from scoring position. A team\'s offensive, defensive, or overall scoring efficiency can be determined.
Inventor(s): Bowman; Robert A. (Westport, CT), Klayman; Gregg (New York, NY), Schwartz; Cory (Merrick, NY)
Assignee: MLB Advanced Media, L.P. (New York, NY)
Application Number:10/979,799
Patent Claims:see list of patent claims

Details for Patent 8,121,712

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial MLB Advanced Media, L.P. (New York, NY) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Johnson and Johnson
McKinsey
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.